Xu Zhenyu

Chief Scientific OfficerSOPHiA GENETICS SA (SOPH) · full profile →Form 4 · filed Aug 7, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$145K
Net Open-Market Flow
-$145K
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 7, 2026Sell(S)7K$7.02$49K601K
Aug 7, 2026Option exercise(M)7K$3.28$23K608K
Aug 7, 2026Sell(S)10K$7.48$75K591K
Aug 5, 2026Option exercise(M)3K$3.28$10K604K
Aug 5, 2026Sell(S)3K$7.00$21K601K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 7, 2026Option exercise(M)7K$3.28$23K0
Aug 5, 2026Option exercise(M)3K$3.28$10K7K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001840706-26-000275) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about SOPH insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001840706-26-000275"
Ask your agent
Use Arkolith to summarize insider buying and selling at SOPHiA GENETICS SA
over the last 90 days and cite the filings.